Investors are ostensibly keeping Catalyst Pharmaceuticals' P...
Investors are ostensibly keeping Catalyst Pharmaceuticals' P/E high due to expectations of its future growth surpassing the market. Currently, shareholders are confident in future earnings and do not foresee a significant dip in the share price in the near future.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000017688cce53558c.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment